Discovery of Natural Potent HMG‐CoA Reductase Degraders for Lowering Cholesterol

Author:

Su Xiao‐Zheng1,Zhang Lin‐Fei1,Hu Kun1,An Yang2,Zhang Qiao‐Peng1,Tang Jian‐Wei1,Yan Bing‐Chao1,Li Xing‐Ren1,Cai Jie3,Li Xiao‐Nian1,Sun Han‐Dong1,Jiang Shi‐You1,Puno Pema‐Tenzin1ORCID

Affiliation:

1. State Key Laboratory of Phytochemistry and Plant Resources in West China Yunnan Key Laboratory of Natural Medicinal Chemistry Kunming Institute of Botany University of Chinese Academy of Sciences Chinese Academy of Sciences Kunming 650201 China

2. Gene Editing Center, School of Life Science and Technology ShanghaiTech University Shanghai 201210 (China)

3. The Germplasm Bank of Wild Species Kunming Institute of Botany University of Chinese Academy of Sciences Chinese Academy of Sciences Kunming 650201 China

Abstract

AbstractExploitation of key protected wild plant resources makes great sense, but their limited populations become the major barrier. A particular strategy for breaking this barrier was inspired by the exploration of a resource‐saving fungal endophyte Penicillium sp. DG23, which inhabits the key protected wild plant Schisandra macrocarpa. Chemical studies on the cultures of this strain afforded eight novel indole diterpenoids, schipenindolenes A−H (18), belonging to six diverse skeleton types. Importantly, semisyntheses suggested some key nonenzymatic reactions constructing these molecules and provided targeted compounds, in particular schipenindolene A (Spid A, 1) with low natural abundance. Remarkably, Spid A was the most potent HMG‐CoA reductase (HMGCR) degrader among the indole diterpenoid family. It degraded statin‐induced accumulation of HMGCR protein, decreased cholesterol levels and acted synergistically with statin to further lower cholesterol. Mechanistically, transcriptomic and proteomic profiling suggested that Spid A potentially activated the endoplasmic reticulum‐associated degradation (ERAD) pathway to enhance the degradation of HMGCR, while simultaneously inhibiting the statin‐activated expression of many key enzymes in the cholesterol and fatty acid synthesis pathways, thereby strengthening the efficacy of statins and potentially reducing the side effects of statins. Collectively, this study suggests the potential of Spid A for treating cardiovascular disease.

Funder

National Science Fund for Distinguished Young Scholars

National Natural Science Foundation of China

Yunnan Provincial Science and Technology Department

Publisher

Wiley

Subject

General Chemistry,Catalysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3